RVNC
Revance Therapeutics Inc
Price:  
3.02 
USD
Volume:  
3,698,169.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC WACC - Weighted Average Cost of Capital

The WACC of Revance Therapeutics Inc (RVNC) is 8.0%.

The Cost of Equity of Revance Therapeutics Inc (RVNC) is 9.10%.
The Cost of Debt of Revance Therapeutics Inc (RVNC) is 7.00%.

Range Selected
Cost of equity 7.10% - 11.10% 9.10%
Tax rate 0.10% - 0.10% 0.10%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.0% - 9.0% 8.0%
WACC

RVNC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.69 1.12
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 11.10%
Tax rate 0.10% 0.10%
Debt/Equity ratio 1.08 1.08
Cost of debt 7.00% 7.00%
After-tax WACC 7.0% 9.0%
Selected WACC 8.0%